The results of the PLATEDIAN study, in which three members of our group participated, have just been published in the prestigious journal Diabetes Care. Specifically, the study shows that the use of telemedicine in patients with type 1 diabetes and glycosylated haemoglobin less than 8% leads to similar therapeutic benefits in terms of efficacy and safety as face-to-face visits. This finding paves the way for using telemedicine in favour of greater comfort for these patients. You can consult this study at https://care.diabetesjournals.org/content/early/2019/12/11/dc19-0739
